ACRS - Aclaris Therapeutics GAAP EPS of -$0.41 beats by $0.07 revenue of $9.28M
2023-11-06 07:20:03 ET
More on Aclaris Therapeutics
- Aclaris Therapeutics: The Many Lives Of This Biopharmaceutical Developer
- Aclaris Therapeutics rises 13% on insider buy
- Seeking Alpha’s Quant Rating on Aclaris Therapeutics
- Historical earnings data for Aclaris Therapeutics
- Financial information for Aclaris Therapeutics
For further details see:
Aclaris Therapeutics GAAP EPS of -$0.41 beats by $0.07, revenue of $9.28M